RecruitingNCT03521648

Database for the Assessment of Efficacy and Safety of BPH Treatment


Sponsor

Dominik Abt

Enrollment

500 participants

Start Date

Jul 7, 2017

Study Type

OBSERVATIONAL

Conditions

Summary

This registry study aims to collect data on efficacy and safety of different treatments of benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH-LUTS).


Eligibility

Sex: MALEMin Age: 18 Years

Inclusion Criteria3

  • All patients treated for BPH / LUTS / prostatic obstruction at the urological department of KSSG
  • Patient age ≥ 18 years
  • Informed consent provided

Exclusion Criteria1

  • Cognitive impairment not allowing Informed Consent or adequate data assessment.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPAE

Prostatic artery embolization

PROCEDURETURP

Transurethral resection of the prostate

PROCEDUREOther

Other surgical procedures for BPH treatment including holmium laser enucleation of the prostate, open prostatectomy, thulium laser vaporization, resection or enucleation, transurethral incision of the prostate


Locations(1)

St. Gallen Cantonal Hospital

Sankt Gallen, Canton of St. Gallen, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03521648


Related Trials